Castle Biosciences (CSTL) Interest Coverage Ratio Growth (3y) (2021 - 2026)
Castle Biosciences (CSTL) Interest Coverage Ratio Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 2.45% |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | -6.12% |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | -53.05% |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 3.64% |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | -6.08% |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | 78.37% |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | 49.22% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | -1.69% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | -16.05% |
| 10 | Castle Biosciences | 919.57 Mn | 652.76 Mn | 79.85 Mn | 54.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 54.09% |
| Mar 31, 2026 | 93.68% |
| Dec 31, 2025 | 59.00% |
| Sep 30, 2025 | 18.19% |
| Jun 30, 2025 | -20.24% |
| Mar 31, 2025 | -1,378.41% |
| Dec 31, 2024 | 25.99% |
| Sep 30, 2024 | 508.85% |
| Jun 30, 2024 | 601.60% |
| Mar 31, 2024 | -2,250.46% |
| Dec 31, 2023 | -616.97% |
| Sep 30, 2023 | -214.73% |
| Jun 30, 2023 | -604.81% |
| Mar 31, 2023 | -6,774.19% |
| Dec 31, 2022 | -122.41% |
| Sep 30, 2022 | -109.32% |
| Jun 30, 2022 | -63.89% |
| Mar 31, 2022 | -17.37% |
| Dec 31, 2021 | -234.75% |
| Sep 30, 2021 | 71.76% |